• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体通过AMPK/mTOR信号通路在急性肝缺血再灌注损伤中发挥重要作用。

PPAR Plays an Important Role in Acute Hepatic Ischemia-Reperfusion Injury via AMPK/mTOR Pathway.

作者信息

Wu Liwei, Yu Qiang, Cheng Ping, Guo Chuanyong

机构信息

Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

Department of Gerontology, Shanghai Minhang District Central Hospital, Shanghai 201100, China.

出版信息

PPAR Res. 2021 Jul 3;2021:6626295. doi: 10.1155/2021/6626295. eCollection 2021.

DOI:10.1155/2021/6626295
PMID:34285690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8275421/
Abstract

BACKGROUND

Hepatic ischemia-reperfusion (IR) injury is one of the severe complications associated with liver surgery and leads to liver dysfunction. PPAR is always linked with various physiologic pathways, and it can alleviate liver damage in IR injury.

AIM

In this study, we explored the potential mechanism of PPAR in the pathogenesis of hepatic IR injury by mice model.

METHODS

After treated with si-PPAR or rosiglitazone, mice were subjected to hepatic ischemia-reperfusion. Liver tissue and blood samples were collected to evaluate liver injury and detected relative mRNA and protein expressions.

RESULTS

The expression of PPAR was increased after reperfusion. And the alleviation of PPAR aggravated the liver damage in IR; at the same time, upregulation of the expression of PPAR released the liver damage. And these effects of PPAR in IR were related to the AMPK/mTOR/autophagy signaling pathway.

CONCLUSION

PPAR plays an important role in hepatic IR injury at least partly via the AMPK/mTOR/autophagy pathway.

摘要

背景

肝缺血再灌注(IR)损伤是肝手术相关的严重并发症之一,可导致肝功能障碍。过氧化物酶体增殖物激活受体(PPAR)总是与各种生理途径相关联,并且它可以减轻IR损伤中的肝损伤。

目的

在本研究中,我们通过小鼠模型探索PPAR在肝IR损伤发病机制中的潜在机制。

方法

用小干扰RNA(si-PPAR)或罗格列酮处理后,对小鼠进行肝缺血再灌注。收集肝组织和血液样本以评估肝损伤,并检测相关的信使核糖核酸(mRNA)和蛋白质表达。

结果

再灌注后PPAR的表达增加。PPAR表达的降低加重了IR中的肝损伤;同时,PPAR表达的上调减轻了肝损伤。PPAR在IR中的这些作用与腺苷酸活化蛋白激酶(AMPK)/雷帕霉素靶蛋白(mTOR)/自噬信号通路有关。

结论

PPAR至少部分通过AMPK/mTOR/自噬途径在肝IR损伤中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/4ff8af8a330b/PPAR2021-6626295.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/4509f9ec03df/PPAR2021-6626295.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/a6e7fbfc2493/PPAR2021-6626295.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/4b48d839d5e2/PPAR2021-6626295.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/c84bde3fa6e9/PPAR2021-6626295.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/09d819cfd28d/PPAR2021-6626295.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/4ff8af8a330b/PPAR2021-6626295.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/4509f9ec03df/PPAR2021-6626295.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/a6e7fbfc2493/PPAR2021-6626295.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/4b48d839d5e2/PPAR2021-6626295.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/c84bde3fa6e9/PPAR2021-6626295.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/09d819cfd28d/PPAR2021-6626295.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29f/8275421/4ff8af8a330b/PPAR2021-6626295.006.jpg

相似文献

1
PPAR Plays an Important Role in Acute Hepatic Ischemia-Reperfusion Injury via AMPK/mTOR Pathway.过氧化物酶体增殖物激活受体通过AMPK/mTOR信号通路在急性肝缺血再灌注损伤中发挥重要作用。
PPAR Res. 2021 Jul 3;2021:6626295. doi: 10.1155/2021/6626295. eCollection 2021.
2
IL37 overexpression inhibits autophagy and apoptosis induced by hepatic ischemia reperfusion injury via modulating AMPK/mTOR/ULLK1 signalling pathways.IL37 通过调控 AMPK/mTOR/ULLK1 信号通路抑制肝缺血再灌注损伤诱导的自噬和凋亡。
Life Sci. 2021 Jul 1;276:119424. doi: 10.1016/j.lfs.2021.119424. Epub 2021 Mar 27.
3
Pretreatment with the ALDH2 activator Alda‑1 protects rat livers from ischemia/reperfusion injury by inducing autophagy.ALDH2 激活剂 Alda-1 通过诱导自噬保护大鼠肝脏免于缺血/再灌注损伤。
Mol Med Rep. 2020 Sep;22(3):2373-2385. doi: 10.3892/mmr.2020.11312. Epub 2020 Jul 8.
4
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice.过氧化物酶体增殖物激活受体γ可保护小鼠免受肝脏缺血/再灌注损伤。
Hepatology. 2008 Jan;47(1):215-24. doi: 10.1002/hep.21963.
5
Cafestol preconditioning attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting ERK/PPARγ pathway.咖啡醇预处理通过抑制 ERK/PPARγ 通路减轻肝缺血再灌注损伤中的细胞凋亡和自噬。
Int Immunopharmacol. 2020 Jul;84:106529. doi: 10.1016/j.intimp.2020.106529. Epub 2020 Apr 27.
6
Spermidine ameliorates liver ischaemia-reperfusion injury through the regulation of autophagy by the AMPK-mTOR-ULK1 signalling pathway.精胺通过调节 AMPK-mTOR-ULK1 信号通路改善肝缺血再灌注损伤。
Biochem Biophys Res Commun. 2019 Nov 5;519(2):227-233. doi: 10.1016/j.bbrc.2019.08.162. Epub 2019 Sep 4.
7
Puerarin protects rat brain against ischemia/reperfusion injury by suppressing autophagy the AMPK-mTOR-ULK1 signaling pathway.葛根素通过抑制自噬的AMPK-mTOR-ULK1信号通路保护大鼠脑免受缺血/再灌注损伤。
Neural Regen Res. 2018 Jun;13(6):989-998. doi: 10.4103/1673-5374.233441.
8
Targeting autophagy to modulate hepatic ischemia/reperfusion injury: A comparative study between octreotide and melatonin as autophagy modulators through AMPK/PI3K/AKT/mTOR/ULK1 and Keap1/Nrf2 signaling pathways in rats.靶向自噬调节肝缺血/再灌注损伤:奥曲肽和褪黑素作为自噬调节剂通过 AMPK/PI3K/AKT/mTOR/ULK1 和 Keap1/Nrf2 信号通路在大鼠中的比较研究。
Eur J Pharmacol. 2021 Apr 15;897:173920. doi: 10.1016/j.ejphar.2021.173920. Epub 2021 Feb 9.
9
PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia/reperfusion injury.过氧化物酶体增殖物激活受体 γ 激动剂吡格列酮可挽救肾缺血再灌注损伤引起的肝损伤。
Toxicol Appl Pharmacol. 2019 Jan 1;362:86-94. doi: 10.1016/j.taap.2018.10.022. Epub 2018 Oct 26.
10
Isoflurane Preconditioning Alleviated Murine Liver Ischemia and Reperfusion Injury by Restoring AMPK/mTOR-Mediated Autophagy.异氟醚预处理通过恢复 AMPK/mTOR 介导的自噬减轻小鼠肝缺血再灌注损伤。
Anesth Analg. 2017 Oct;125(4):1355-1363. doi: 10.1213/ANE.0000000000002385.

引用本文的文献

1
Protective effect of irbesartan against hepatic ischemia-reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats.厄贝沙坦对大鼠肝脏缺血再灌注损伤的保护作用:ERK、STAT3和PPAR-γ炎症通路在大鼠中的作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1681-1693. doi: 10.1007/s00210-024-03301-6. Epub 2024 Aug 21.
2
An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases.过氧化物酶体增殖物激活受体在肝脏疾病中的作用概述
J Clin Transl Hepatol. 2023 Dec 28;11(7):1542-1552. doi: 10.14218/JCTH.2023.00334. Epub 2023 Nov 15.

本文引用的文献

1
Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis.吉西他滨和雷帕霉素通过靶向自噬和凋亡对骨肉瘤具有相加作用。
Cancers (Basel). 2020 Oct 23;12(11):3097. doi: 10.3390/cancers12113097.
2
Catalpol Ameliorates Insulin Sensitivity and Mitochondrial Respiration in Skeletal Muscle of Type-2 Diabetic Mice Through Insulin Signaling Pathway and AMPK/SIRT1/PGC-1α/PPAR-γ Activation.梓醇通过激活胰岛素信号通路和 AMPK/SIRT1/PGC-1α/PPAR-γ 改善 2 型糖尿病小鼠骨骼肌胰岛素敏感性和线粒体呼吸功能。
Biomolecules. 2020 Sep 24;10(10):1360. doi: 10.3390/biom10101360.
3
Insight on Transcriptional Regulation of the Energy Sensing AMPK and Biosynthetic mTOR Pathway Genes.
能量感应AMPK和生物合成mTOR通路基因转录调控的见解
Front Cell Dev Biol. 2020 Jul 29;8:671. doi: 10.3389/fcell.2020.00671. eCollection 2020.
4
The PPAR Pocket: Renewed Opportunities for Drug Development.PPAR 口袋:药物研发的新机遇
PPAR Res. 2020 Jul 1;2020:9657380. doi: 10.1155/2020/9657380. eCollection 2020.
5
Redox Regulation of PPAR in Polarized Macrophages.极化巨噬细胞中PPAR的氧化还原调节
PPAR Res. 2020 Jul 1;2020:8253831. doi: 10.1155/2020/8253831. eCollection 2020.
6
Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma.过氧化物酶体增殖物激活受体作为哮喘的治疗靶点
PPAR Res. 2020 Jan 14;2020:8906968. doi: 10.1155/2020/8906968. eCollection 2020.
7
PPARs and the Development of Type 1 Diabetes.过氧化物酶体增殖物激活受体与1型糖尿病的发展
PPAR Res. 2020 Jan 9;2020:6198628. doi: 10.1155/2020/6198628. eCollection 2020.
8
Therapeutic potential of PPARγ natural agonists in liver diseases.过氧化物酶体增殖物激活受体 γ 天然激动剂在肝脏疾病中的治疗潜力。
J Cell Mol Med. 2020 Mar;24(5):2736-2748. doi: 10.1111/jcmm.15028. Epub 2020 Feb 7.
9
15-Deoxy-∆--Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-: Function and Mechanism.15-脱氧-Δ¹²-前列腺素J2(15d-PGJ2),过氧化物酶体增殖物激活受体-γ的内源性配体:功能与机制
PPAR Res. 2019 Aug 1;2019:7242030. doi: 10.1155/2019/7242030. eCollection 2019.
10
Effect of Telmisartan in the Oxidative Stress Components Induced by Ischemia Reperfusion in Rats.替米沙坦对大鼠缺血再灌注诱导的氧化应激成分的影响。
Oxid Med Cell Longev. 2019 Jul 2;2019:1302985. doi: 10.1155/2019/1302985. eCollection 2019.